Indication
Ocular Hypertension
4 clinical trials
6 products
Clinical trial
A Randomized, Multi-site, Double-masked Study Evaluating the Safety and Tolerability of QLS-111 vs Vehicle in Primary Open-angle Glaucoma or Ocular Hypertension PatientsStatus: Recruiting, Estimated PCD: 2024-09-05
Product
QLS-111Product
QLS-111 ophthalmic solutionClinical trial
Aqueous Humor Dynamic Components That Determine Intraocular Pressure VarianceStatus: Recruiting, Estimated PCD: 2024-07-01
Product
TimololProduct
LatanoprostClinical trial
A Randomized, Single Center, Masked, Crossover Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity in Patients With Ocular Hypertension or Primary Open Angle GlaucomaStatus: Completed, Estimated PCD: 2021-05-20
Product
Latanoprostene BunodProduct
Timolol maleateClinical trial
A Pilot, Double-masked, Vehicle-controlled, Randomized Study to Evaluate the Safety and Tolerability of QLS-111 Versus Vehicle in Combination With Latanoprost Treatment in Subjects With Open-angle Glaucoma and/or Ocular HypertensionStatus: Recruiting, Estimated PCD: 2024-10-05